Variant NM_000492.4:c.902A>G


Variant details:
Name NM_000492.4:c.902A>G
Protein name NP_000483.3:p.(Tyr301Cys)
Genomic name (hg19) chr7:g.117180186A>G    UCSC    gnomAD
#Exon/intron exon 8
Legacy Name Y301C
Class VUS
Subclass VUS2
WT sequence CTGAAACTGACTCGGAAGGCAGCCT A TGTGAGATACTTCAATAGCTCAGCC
Mutant sequence CTGAAACTGACTCGGAAGGCAGCCT G TGTGAGATACTTCAATAGCTCAGCC


External sources:

Not found		dbSNP
rs150691494






Pathogenicity predictions:
AGVGD MAPP SIFT PPH2
C25 0.01855 0.01 0.992
VUS2 VUS4 VUS5 VUS5

Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing




No patient found in CFTR-NGS catalogue


3 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 3
Asymptomatic compound heterozygote 2
CFTR-RD1
  • CBAVD  1



Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Asymptomatic compound heterozygote 5245heterozygoteVUS1 - Trans
VUS3 - Trans
Asymptomatic compound heterozygote 5255heterozygoteVUS3- Undef
CBAVD 4487heterozygoteVUS1- Undef


Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.